Hernán A. Navarro

Gobierno de Navarra — Spain

Biochemistry, Genetics and Molecular Biology · Life Sciences

34h-index3.7kcitations156works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Receptor Mechanisms and Signaling(51), Nicotinic Acetylcholine Receptors Study(40), Neuropeptides and Animal Physiology(32), Pharmacological Receptor Mechanisms and Effects(27), Neurotransmitter Receptor Influence on Behavior(20)

Publications156 total

Innovative ablation technique for cancer patients: assessing pulsed field ablation in atrial fibrillation
European Heart Journal Supplements·2025Open Access
Identification of Inhibitors of <i>Chikungunya</i> virus nsP2 ATPase
2024· 3 citedOpen Access
Building towards societal inclusion in the biomanufacturing workforce: A developing model in North Carolina
Industry and Higher Education·2024Open Access
Reactivity of renal and mesenteric resistance vessels to angiotensin II is mediated by NOXA1/NOX1 and superoxide signaling
American Journal of Physiology-Renal Physiology·2023· 7 citedOpen Access
4β-Methyl-5-(3-hydroxyphenyl)morphan Opioid Agonist and Partial Agonist Derived from a 4β-Methyl-5-(3-hydroxyphenyl)morphan Pure Antagonist
Figshare·2020Open Access
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3<i>R</i>)-7-Hydroxy-<i>N</i>-[(1<i>S</i>)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (PDTic)
Journal of Medicinal Chemistry·2018· 10 cited
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3<i>R</i>)-<i>N</i>-[1<i>R</i>)-1-(Cyclohexylmethyl)-2-methylpropyl]-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (CDTic)
Journal of Medicinal Chemistry·2018· 6 cited
Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse
PLoS ONE·2017· 85 citedOpen Access
Simple Tetrahydroisoquinolines Are Potent and Selective Kappa Opioid Receptor Antagonists
ACS Medicinal Chemistry Letters·2017· 10 citedOpen Access
Synthesis, Nicotinic Acetylcholine Receptor Binding, and in Vitro and in Vivo Pharmacological Properties of 2′-Fluoro-(substituted thiophenyl)deschloroepibatidine Analogues
ACS Chemical Neuroscience·2016· 1 cited
Design, Synthesis, and Biological Evaluation of Structurally Rigid Analogues of 4-(3-Hydroxyphenyl)piperidine Opioid Receptor Antagonists
The Journal of Organic Chemistry·2016· 10 citedOpen Access
Design, synthesis, and pharmacological evaluation of JDTic analogs to examine the significance of replacement of the 3-hydroxyphenyl group with pyridine or thiophene bioisosteres
Bioorganic & Medicinal Chemistry·2016· 6 citedOpen Access
Synthesis, Nicotinic Acetylcholine Binding, and in Vitro and in Vivo Pharmacological Properties of 2′-Fluoro-(carbamoylpyridinyl)deschloroepibatidine Analogues
ACS Chemical Neuroscience·2016· 5 cited
Corrigendum to “A selective delta opioid receptor antagonist based on a stilbene core
2016
Corrigendum to “A selective delta opioid receptor antagonist based on a stilbene core” [Bioorg. Med. Chem. Lett. 25 (2015) 5532–5535]
Bioorganic & Medicinal Chemistry Letters·2016
CCDC 1480747: Experimental Crystal Structure Determination
The Cambridge Structural Database·2016Open Access
CCDC 1480746: Experimental Crystal Structure Determination
The Cambridge Structural Database·2016Open Access
A selective delta opioid receptor antagonist based on a stilbene core
Bioorganic & Medicinal Chemistry Letters·2015· 4 citedOpen Access
Novel Synthesis and Pharmacological Characterization of NOP Receptor Agonist 8-[(1<i>S</i>,3a<i>S</i>)-2,3,3a,4,5,6-Hexahydro-1<i>H</i>-phenalen-1-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (Ro 64-6198)
ACS Chemical Neuroscience·2015· 17 citedOpen Access
Design, synthesis, and pharmacological evaluation of JDTic analogs to examine the significance of the 3- and 4-methyl substituents
Bioorganic & Medicinal Chemistry·2015· 17 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

F. Ivy Carroll(15), Mansukh C. Wani(10), Norman R. Farnsworth(9), A. Douglas Kinghorn(9), Monroe E. Wall(9), S. Wayne Mascarella(9), Billy R. Martin(8), Lawrence E. Brieaddy(8), Philip Abraham(7), Bruce E. Blough(6), F. Ivy Carroll(6), M. Imad Damaj(6), M. Imad Damaj(5), Ronald J. Lukas(5), Jason P. Burgess(5), T A Slotkin(4), Nicholas H. Oberlies(4), Scott P. Runyon(4), Thomas E. Prisinzano(4), Brian P. Gilmour(4)